Following a recent and successful increase in its global market presence, Dr Roebuck's, the Australian-based clean skincare brand, receives a growth capital investment led by Unilever Ventures to accelerate growth.
WHO: Sisters Zoe and Kim Roebuck founded Dr Roebuck's in 2016 as a way to honor their parents, who, as physicians, created a one-of-a-kind clean, Australian-inspired formula that successfully treated their eczema and dry, sensitive skin. The original Dr Roebuck formula, which quickly developed a cult following in their hometown of Bondi Beach, serves as the foundation and inspiration for the brand's diverse and innovative product line.
Unilever Ventures is the venture capital and private equity arm of Unilever. They invest in early-stage, promising companies, accelerating growth by providing access to Unilever's global ecosystem, assets, and expertise. The fund looks to invest in tomorrow's world-beaters in Personal Care, eCommerce, and Digital Transformation.
WHY: The new capital will be used to accelerate the brand's market growth, enhance the company's infrastructure, and strategically invest in product innovation and R&D.
IN THEIR OWN WORDS: "We’re now in 2,000 stores across 20 countries," Chief Executive Officer Natalie Sperling told WWD. “Being such an indie, small brand, we now have this huge footprint to support…and we really want to focus and drive sell-through on these key accounts. It was really important to partner with a strategic financial company that wasn’t purely just capital because of the opportunity we had. The round closed in early April."
Dr Roebuck's appealed to us because it is a brand that really lives and breathes clean beauty and its Australian lifestyle roots," says Rachel Harris, Director of Unilever Ventures. "We look forward to working with Kim, Zoe and Natalie to help further drive Dr Roebuck's international growth plans.
DETAILS:
